Clinical Trials

530 enrolled 25 charts

Carcinoma, Non-Small-Cell Lung

NCT00483561 2023-09-13

Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy

26 enrolled 7 charts

Prostatic Neoplasms

NCT00352079 2023-08-04

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

41 enrolled

Urinary Bladder Neoplasms

NCT03599518 2023-02-08

DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Phase 1 Terminated

20 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT02025218 2021-04-01

IRENE

21 enrolled

Lung Neoplasms

NCT02893332 2021-02-03

Sindas

200 enrolled

Stage IV EGFR Mutated Non-Small Cell Lung Cancer

NCT00493025 2018-12-06

Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery

19 enrolled 4 charts

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT02326285 2018-01-23

NeoIntercal

Phase 2/3 Terminated

1 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02299765 2017-11-27

Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC

Phase 4 Terminated

61 enrolled

Non-small Cell Lung Cancer Metastatic

NCT00206492 2017-08-01

Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients

3 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT01310855 2017-05-31

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

38 enrolled 8 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00467077 2017-03-17

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

21 enrolled 8 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01405846 2016-08-19

TIDAL1

32 enrolled

Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

NCT00479089 2015-11-02

Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer

50 enrolled 5 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00093652 2015-10-06

Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00088907 2015-05-06

Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer

270 enrolled 8 charts

Head and Neck Neoplasms

NCT00198159 2014-09-19

IUCRO-0021

21 enrolled

Neoplasms, Germ Cell and Embryonal

NCT01363557 2014-05-13

ARPEGE

Phase NA Terminated

1 enrolled

CNSThoracic

Brain Neoplasms, Lung Neoplasms

NCT00290719 2014-05-09

Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Phase 1 Terminated

6 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00258297 2013-10-16

Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery

30 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00536107 2013-10-01

Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Terminated

14 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00082667 2013-02-25

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

1 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00206414 2013-02-05

Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer

15 enrolled

Breast

Breast Neoplasms

NCT00087334 2013-02-01

Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer

10 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00033449 2013-01-25

Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 1 Terminated

30 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT00052585 2013-01-16

Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer

50 enrolled

Colonic Neoplasms, Rectal Neoplasms

NCT00104728 2012-10-31

Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates

Phase NA Terminated

42 enrolled 3 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00091156 2012-07-16

Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

598 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00169221 2011-11-15

Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas

54 enrolled

Head and Neck Neoplasms

NCT00234468 2011-05-20

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

490 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00234442 2009-06-30

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

47 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00237900 2009-04-23

Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer

34 enrolled

Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC

NCT00195078 2007-07-20

Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer

29 enrolled